Showing results (81-90 of 361) with videos related to
Sort By:
Pageof 37
Drugs|November 9, 2022
Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase InhibitorsFrancesco Locatelli, Roberto Minutolo, Luca De Nicola, et al.Kidney International. Supplement|December 23, 2004
Is it the agent or the blood pressure level that matters for renal and vascular protection in chronic nephropathies?Francesco Locatelli, Lucia Del Vecchio, Pietro Pozzoni, et al.Clinical Kidney Journal|August 2, 2016
Pure red cell aplasia induced by epoetin zetaVincenzo Panichi, Guido Ricchiuti, Alessia Scatena, et al.Contributions to Nephrology|June 1, 2011
Recent trials on hemodiafiltrationFrancesco Locatelli, Celestina Manzoni, Lucia Del Vecchio, et al.Drug Discovery Today|August 23, 2011
The regulatory framework of biosimilars in the European UnionPaola Minghetti, Paolo Rocco, Francesco Cilurzo, et al.Expert Opinion on Pharmacotherapy|June 28, 2024
Can we effectively manage chronic kidney disease with a precision-based pharmacotherapy plan? Where are we?Francesco Locatelli, Ernesto Paoletti, Maura Ravera, et al.Journal of Nephrology|December 16, 2004
Long-term outcome in hemodialysis: morbidity and mortalityPietro Pozzoni, Lucia Del Vecchio, Giuseppe Pontoriero, et al.Drugs|May 22, 2024
Drugs in Development to Treat IgA NephropathyLucia Del Vecchio, Marco Allinovi, Stefania Comolli, et al.Clinical Kidney Journal|September 29, 2015
Optimizing haemodialysate compositionFrancesco Locatelli, Vincenzo La Milia, Leano Violo, et al.Contributions to Nephrology|October 13, 2010
Management of anemia by convective treatmentsFrancesco Locatelli, Celestina Manzoni, Lucia Del Vecchio, et al.Pageof 37